Quote
|
Profile
|
Overview
|
Calendar
|
Email Alert
|
Request Information
|
My b2i™
Analysts
|
Governance
|
Downloads
|
News
|
Contact Us
Outlook Therapeutics® Submits Special Protocol Assessment (SPA) to FDA for Non-Inferiority Study of ONS-5010
Lipocine to Present at Biotech Showcase 2024
Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm
Alopecia Market Size Is Expected To Reach $7.8 Billion In 2028 At A CAGR Of 7.9% As Per The Business Research Company's Alopecia Global Market Report 2024
First Shipment of RiVive™ Brings Life-saving Over-The-Counter Nalxone Nasal Spray One Step Closer to Those Who Need It Most
Inspira Technologies to Participate in J.P. Morgan Healthcare Conference
Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastoma
Tyber Medical Granted FDA Clearance on Distal Radius Plating System
Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis
Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix™
6
7
8
9
10
11
12
13
14
15
16
<<
<
>
>>
Privacy